EP 0693123 A1 19960124 - MODIFIED OLIGONUCLEOTIDES HAVING IMPROVED ANTI-INFLUENZA ACTIVITY
Title (en)
MODIFIED OLIGONUCLEOTIDES HAVING IMPROVED ANTI-INFLUENZA ACTIVITY
Title (de)
Veränderte Oligonukleotide mit verbesserter anti-grippe Aktivität
Title (fr)
OLIGONUCLEOTIDES MODIFIES AYANT UNE ACTIVITE ANTIGRIPPE AMELIOREE
Publication
Application
Priority
- US 9403454 W 19940330
- US 4075293 A 19930331
Abstract (en)
[origin: WO9423028A2] The invention provides anti-influenza modified oligonucleotides that have greater efficacy in inhibiting influenza replication or propagation than previously described oligonucleotides. The greater efficacy arises from structural features such as chimeric or hybrid backbones, nuclease resistance-conferring terminal capping structures and/or self-complementary regions.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 31/70 (2006.01); A61K 48/00 (2006.01); A61P 31/12 (2006.01); A61P 31/16 (2006.01); C07H 21/00 (2006.01); C07H 21/04 (2006.01); C12N 15/113 (2010.01)
CPC (source: EP)
A61P 31/12 (2017.12); A61P 31/16 (2017.12); C07H 21/00 (2013.01); C12N 15/1131 (2013.01)
Citation (search report)
See references of WO 9423028A2
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9423028 A2 19941013; WO 9423028 A3 19950216; AU 6527094 A 19941024; CA 2159350 A1 19941013; CN 1124980 A 19960619; EP 0693123 A1 19960124; JP H08510900 A 19961119; NZ 263985 A 19970727
DOCDB simple family (application)
US 9403454 W 19940330; AU 6527094 A 19940330; CA 2159350 A 19940330; CN 94192300 A 19940330; EP 94912901 A 19940330; JP 52231794 A 19940330; NZ 26398594 A 19940330